Mothers’ preferences and willingness-to-pay for human papillomavirus vaccines in Iran: A discrete choice experiment study

Sargazi, Nasrin; Takian, Amirhossein; Yaseri, Mehdi; Daroudi, Rajabali; Motlagh, Ali Ghanbari; Nahvijou, Azin; Zendehdel, Kazem

doi:10.1016/j.pmedr.2021.101438

Cited by 6 publications

(14 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several studies have used DCEs to understand preferences for COVID‐19 vaccination in various countries, including China, Ecuador, and Australia 2,6,21 . Additionally, DCEs have been used to study preferences for vaccinations for other diseases, such as HPV, hepatitis B, and influenza 9–15 . Overall, DCEs appear to be a useful tool for understanding vaccine preferences and can help inform public health policies and interventions.…”

Section: Discussionmentioning

confidence: 99%

“… 2 , 6 , 21 Additionally, DCEs have been used to study preferences for vaccinations for other diseases, such as HPV, hepatitis B, and influenza. 9 , 10 , 11 , 12 , 13 , 14 , 15 Overall, DCEs appear to be a useful tool for understanding vaccine preferences and can help inform public health policies and interventions.…”

Section: Discussionmentioning

confidence: 99%

“…5,12,16 In general, the DCE method is commonly used in healthcare research to understand how individuals make choices between different options with varying attributes. 5,13,[17][18][19][20] In the context of the COVID-19 vaccine, the DCE can help to identify which attributes of the vaccine are most important to individuals when deciding whether or not to get vaccinated, and how different levels of these attributes may affect their preferences. Some studies have used DCE to examine factors that determine preference for COVID-19 vaccination.…”

Section: Methodsmentioning

confidence: 99%

“…To use the DCE method, it is crucial to select the vaccine attributes and their levels. 18 The attributes and levels were identified based on prior studies, which were not limited to COVID‐19 6 , 7 , 21 but also included other topics such as seasonal influenza, 11 , 18 HPV, 12 , 13 , 14 , 15 and hepatitis B. 9 , 10 Additionally, the vaccine experts were utilized as a source of information for this purpose.…”

Section: Methodsmentioning

confidence: 99%

“…Multiple studies have been conducted regarding individuals' preference for vaccination against hepatitis B virus, 9 , 10 seasonal influenza, 11 and human Papillomavirus (HPV), 12 , 13 , 14 , 15 which investigated various factors that influence individuals' decisions to choose vaccination programs. These factors include individuals' characteristics (age, education level, gender, and income) and the vaccine's side effects, effectiveness, duration of protection, cost, and the number of doses.…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Investigating preferences of the covid‐19 vaccine among individuals in Iran: Discrete choice experiment analysis

Parvizi

Mehrara

Taiebnia

2023

Health Science Reports

View full text Add to dashboard Cite

Background and Aims This study aimed to estimate the preferences for COVID‐19 vaccines among a sample of Iranian adults and to understand the sources of preference heterogeneity. Methods A web‐based survey was conducted from April to July 2021; out of 1747 participants, 678 completed the survey. Seven key attributes were selected, namely effectiveness, risk of severe side effects, risk of mild side effects, number of doses, duration of protection, location of manufacture, and price. Additionally, conditional logit and mixed logit models were used to analyze the data. Results The results of this study indicate that vaccine effectiveness, protective duration, the risk of side effects, and price are the most important factors that influence vaccine preferences. Furthermore, we identified heterogeneity in preferences, indicating that not all individuals respond in the same way to vaccine attributes. Conclusion The majority of Iranians prefer to get the Covid‐19 vaccine. Policymakers should consider these findings when implementing successful programs. This study contributes to the literature by estimating Iranian respondents' preferences for the Covid‐19 vaccine and identifying the heterogeneity in their preferences for vaccine attributes. The findings may also inform future research and policies related to Covid‐19 vaccination programs in Iran.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Investigating preferences of the covid‐19 vaccine among individuals in Iran: Discrete choice experiment analysis

Parvizi

Mehrara

Taiebnia

2023

Health Science Reports

View full text Add to dashboard Cite

show abstract

Cost–Benefit Analysis of Human Papillomavirus Vaccine in Iran

et al. 2022

Self Cite

View full text Add to dashboard Cite

Background: Despite increasing global attention to the national human papillomavirus (HPV) immunization program, this program is controversial in Iran. Evidence indicate that HPV vaccination is not cost-effective in Iran. Using cost-effectiveness analysis for decision-making about public health interventions such as vaccination is debated, because its potential bene ts may not t this framework. Our objective was to evaluate economic effects of HPV vaccination by cost-bene t analysis (CBA). In this case, we used bivalent and quadrivalent in Iran in 2020.Methods: We performed a CBA from a societal perspective. We used two approaches of the vaccine's

show abstract

Knowledge, Acceptance, and Willingness to Pay for Human Papillomavirus (HPV) Vaccine: A Systematic Review

Endriyanti,

Endarti,

Phodha

2023

BIO Web Conf.

View full text Add to dashboard Cite

Cervical cancer is the fourth most common type of cancer incidence in women. It has been recognized that Human Papillomavirus (HPV) is causative agent in the pathogenesis of cervical cancer. In 2022, 117 countries have included HPV vaccine in their national immunization program. Understanding participants’ decision regarding their children and themselves being vaccinated is important to ensure high coverage of the vaccine. This study aimed to conduct a systematic review of knowledge, acceptance, and willingness to pay for HPV vaccine. The required information was collected by searching with relevant keywords during OctoberDecember 2022 for articles published from 2013 – 2022 in PubMed, Scopus, ScienceDirect, and SpringerLink. The data were analyzed in Excel and reported descriptively. Finally, 22 studies were included to review. Most of the participants were female (96.44%) and the majority had health workers background (50.09%). The knowledge of mostly results was poor (40.9%). The acceptance of HPV vaccine was high, the range vary from 39–98.8%, especially for the vaccine with higher degree, longer duration of protection, lower out-of-pocket, and lower risk of side effects. Overall, the respondents’ attitude was positive toward vaccination. The most frequent method used for measuring WTP was CVM (54.54%). The average WTP range from 0.1– 17.51% to GDP per capita (9.9–745.25 USD). The cost was the primary reason that impact to the willingness to pay and acceptance. Results showed that the acceptance rate of HPV vaccination and WTP were relatively high when the vaccine was offered for free or reasonable price, even though their knowledge was poor. It is recommended to reduce the cost of vaccination program and to increase knowledge, awareness, and attitude of people.

show abstract

Mothers’ preferences and willingness-to-pay for human papillomavirus vaccines in Iran: A discrete choice experiment study

Cited by 6 publications

References 28 publications

Investigating preferences of the covid‐19 vaccine among individuals in Iran: Discrete choice experiment analysis

Investigating preferences of the covid‐19 vaccine among individuals in Iran: Discrete choice experiment analysis

Cost–Benefit Analysis of Human Papillomavirus Vaccine in Iran

Knowledge, Acceptance, and Willingness to Pay for Human Papillomavirus (HPV) Vaccine: A Systematic Review

Contact Info

Product

Resources

About